RxDoctor Payments Data

Susan Pumphrey

Family · Joplin, MONPI 1134243819

Payments from drug & device makers

$575in general payments, 2019–2025

Across 35 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$116
  • Otsuka America Pharmaceutical, Inc.$64
  • GSK$61
  • Exact Sciences$45
  • Lilly USA, LLC$41
  • Bayer$31
  • plus $218 from 13 others

What the payments were for

  • Food & beverage$575100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$575 in reported general payments places this provider in the 55th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$30,026
Medicare patients
142
Services billed
483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol40$37,595
JardianceEmpagliflozin33$34,328
TrulicityDulaglutide15$23,775
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$22,693
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$12,029
Aimovig AutoinjectorErenumab-Aooe11$10,717
XiidraLifitegrast12$8,941
JanumetSitagliptin Phos/Metformin Hcl12$7,091
Combivent RespimatIpratropium/Albuterol Sulfate11$5,361
Gabapentin134$2,641
Albuterol Sulfate HfaAlbuterol Sulfate88$2,240
Diclofenac Sodium18$2,076
Allopurinol45$1,826
Fluticasone Propionate92$1,703
Omeprazole99$1,266

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$116$49,62453 claims
Boehringer IngelheimJardiance, Combivent Respimat$14$39,68944 claims
Lilly USA, LLCTrulicity$41$23,77515 claims
GSKTrelegy Ellipta$61$22,69328 claims
MerckJanumet$17$7,09112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,812 family providers in Missouri.

Other family in Joplin

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →